Advances in leukemia inhibitors targeting PI3K/AKT/mTOR pathway.
10.3760/cma.j.issn.0253-2727.2015.10.021
- Author:
Le WANG
1
;
Yajing CHU
1
;
Tao CHENG
1
;
Weiping YUAN
1
Author Information
1. Institute of Hematology and Blood Disease Hospital, CAMS/PUMC, State Key Laboratory of Experimental Hematology, Tianjin 300020, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Leukemia;
drug therapy;
Phosphatidylinositol 3-Kinases;
antagonists & inhibitors;
Proto-Oncogene Proteins c-akt;
antagonists & inhibitors;
TOR Serine-Threonine Kinases;
antagonists & inhibitors
- From:
Chinese Journal of Hematology
2015;36(10):888-893
- CountryChina
- Language:Chinese